Borosil Scientific Ltd

Borosil Scientific Limited announced the allotment of 4,475 equity shares following the exercise of vested options under its Borosil Scientific Limited – Employee Stock Option Scheme (BSL-ESOS), increasing the company’s issued and paid-up equity share capital to Rs 8,89,51,525 divided into 8,89,51,525 equity shares. The allotment was approved on August 13, 2026, and received in-principle approval from both the National Stock Exchange of India Limited and BSE Limited on November 11, 2024.

Borosil Scientific Ltd share price declined by 3.61% to Rs 152.2 after the company's net profit plunged by 84% to Rs 4.36 crore, while revenue from operations nosedived 25.44% to Rs 106.75 crore in Q2FY26 over Q1FY26. The market capitalization of Glass - Industrial industry group stocks on BSE stood at Rs 9250.1 crore, slipping 9.64%. It has eased by 4.16% over last one week and advanced by 8.75% in last one month while the market capitalization of Borosil Scientific Ltd has softened by 1.84% and 30.09% in the same period respectively. Profit before tax (PBT) of Borosil Scientific Ltd stood at Rs 5.98 crore in Q2 FY26, crashing by 246.57% year-on-year, and tanking 79.49% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 195.41% YoY and plunging by 80.73% sequentially. Total expenses dropped by 10.91% to Rs 103.18 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 41.01 crore, slightly declining by 7.78% YoY, while employee benefits expense was at Rs 21.98 crore, soaring 22.52% YoY. For the TTM ended FY26, revenue from operations rose 10.74% to Rs 438.49 crore, while net profit expanded by 13.80% to Rs 26.72 crore, compared to previous TTM. EBITDA soared by 4369% to Rs 44.77 crore, and PBT soared 28.02% to Rs 40.39 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 120.03 crore in FY26, as against Rs 30.0 crore in FY25. Borosil Scientific Ltd slipped 3.72% in last one year, performing in line with the benchmark BSE Sensex which has eased by 3.81% during the same period.

Borosil Scientific will hold a meeting of the Board of Directors of the Company on 3 August 2026.

Net profit of Borosil Scientific rose 213.84% to Rs 27.21 crore in the quarter ended March 2026 as against Rs 8.67 crore during the previous quarter ended March 2025. Sales rose 10.57% to Rs 143.17 crore in the quarter ended March 2026 as against Rs 129.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 29.14% to Rs 34.61 crore in the year ended March 2026 as against Rs 26.80 crore during the previous year ended March 2025. Sales rose 6.58% to Rs 467.34 crore in the year ended March 2026 as against Rs 438.49 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales143.17129.48 11 467.34438.49 7 OPM %22.4312.80 -13.3111.99 - PBDT33.9118.72 81 70.6158.87 20 PBT29.1514.02 108 51.3740.39 27 NP27.218.67 214 34.6126.80 29 Powered by Capital Market - Live

The board of Borosil Scientific at its meeting held on 20 May 2026 has decided to seek the approval of the shareholders by way of an enabling resolution at the ensuing Annual General Meeting, authorising the Board to raise funds, as and when required, up to an amount of Rs. 250 crore, using such modes as the Board may determine including by way of qualified institutional placement, further public officer, FCCBs or any other method or a combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals, as may be required.

Borosil Scientific will hold a meeting of the Board of Directors of the Company on 20 May 2026.

Net profit of Borosil Scientific rose 101.86% to Rs 8.68 crore in the quarter ended December 2025 as against Rs 4.30 crore during the previous quarter ended December 2024. Sales rose 19.57% to Rs 121.30 crore in the quarter ended December 2025 as against Rs 101.45 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales121.30101.45 20 OPM %14.179.87 - PBDT19.3511.52 68 PBT14.576.94 110 NP8.684.30 102 Powered by Capital Market - Live

Borosil Scientific will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

Borosil Scientific has received affirmation in credit rating from CARE for bank facilities availed by the company at CARE A+; Stable / CARE A1+. Powered by Capital Market - Live

Net profit of Borosil Scientific declined 67.12% to Rs 2.89 crore in the quarter ended September 2025 as against Rs 8.79 crore during the previous quarter ended September 2024. Sales rose 3.81% to Rs 106.90 crore in the quarter ended September 2025 as against Rs 102.98 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales106.90102.98 4 OPM %7.5115.35 - PBDT9.9517.04 -42 PBT5.1312.41 -59 NP2.898.79 -67 Powered by Capital Market - Live